MedTrace Logo

Tachikawa Project for Prevention of Posttraumatic Stress Disorder With Polyunsaturated Fatty Acid (TPOP): TPOP-02 Study

NCT00671099 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2014-01-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate efficacy and safety of Polyunsaturated Fatty Acid for the prevention of Posttraumatic Stress Disorder (PTSD) in patients with accidental injuries.

Conditions

Interventions

DIETARY_SUPPLEMENT

Omega-3 Polyunsaturated Fatty Acid

A capsule of omega-3 Polyunsaturated Fatty Acid, 300mg (including 70% docosahexaenoic acid, 7% eicosapentaenoic acid and other), 7 capsules per day in 12 week.

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • University of Toyama

    collaborator OTHER

  • Chiba University

    collaborator OTHER

  • Japan Science and Technology Agency

    lead OTHER

Principal Investigators

  • Yutaka Matsuoka, M.D.,Ph.D. · National Disaster Medical Center, Tachikawa, Tokyo ,Japan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2013-08-31
Completion
2013-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00671099 on ClinicalTrials.gov